|
|
Article: PHARSIGHT REVENUES INCREASE 52% FOR 3RD QUARTER.(Pharsight Corp., fiscal year 2001)(Brief Article)(Company Profile)(Statistical Data Included)
- Article from:
- Biotech Financial Reports
- Article date:
- March 1, 2001
CopyrightCOPYRIGHT 2001 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pharsight Corporation (Nasdaq:PHST), Mountain View, Calif., a leading provider of technologies and services that improve the drug development process, has announced results for the third quarter of fiscal 2001. For the quarter ending December 31, 2000, revenue increased 52% to $3.5 million, up from $2.3 million for the quarter ended December 31, 1999.
The company reported a net loss for the quarter of $4.8 million, or ($0.27) per share, compared to a net loss of $2.5 million, or ($0.76) per share (excluding accretion on preferred stock), for the same period in 1999. The increase in net loss is primarily attributed to amortization of deferred stock compensation ...